Latest
-
Black Forest Labs founders Robin Rombach, Andreas Blattmann, and Patrick Esser discuss their new company building state-of-the-art image and video models.
-
Whereas we historically have viewed the low adoption of software as a liability, we now view that as an asset—we don't face the same sunk cost bias that might be slowing other industries down from taking full advantage of the latest AI innovations.
-
Logistics wins wars, and military logistics today means moving fuel. Advanced nuclear microreactors can replace fuel supply chains with on-site power, revolutionizing warfare and saving lives.
-
Bowen Liu, PhD, investing partner, and Surya Ganguli, PhD, venture partner, join Vijay Pande, PhD, general partner of a16z Bio + Health.
-
Vijay Pande walks us through two decades of applying software engineering and AI to biotech and health care — from Folding@Home through AlphaFold and more.
-
Learn which parts of the stack to build or buy, and how to improve out-of-the-box models by helping customers select and ingest the right data.
-
Bruce Levine, PhD, the Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania, joins Jorge Conde, general partner, and Ginger Liau, partner at a16z Bio + Health.
-
Waymo co-CEO Dmitri Dolgov discusses how Waymo is using genAI to help them build safer, sustainable, and more accessible transportation.
-
Blockchains are a way to build new networks, ensuring people have voice and choice in the networks they contribute to and use every day.
-
PromptFoo creator Ian Webster discusses the importance of red-teaming for AI safety and security, and of bringing those capabilities to more organizations.
-
With LLMs and AI-enabled data infrastructure, common sales activities will be redefined and completely new seller workflows will emerge.
-
Martin Casado and Ion Stoica argue that open-source models will power innovation without compromising security.
-
Artists are at the forefront of the AI platform shift. As new high fidelity tools emerge along the creative stack, technology is extending the impact of filmmakers, designers, animators, illustrators, photographers, and multimedia artists.
-
This special episode is all about regional innovation — why are some places hubs of innovation, while others aren't?
-
In this episode, a follow-up to our episode Grand Challenges in Healthcare AI, Julie Yoo and Vijay Pande, a16z general partners, answer audience questions about AI applications in healthcare.
-
Command Zero CTO Dean de Beer discusses how large language models can help with cybersecurity incident response, and how to build products on LLMs.
-
In this talk, Juan Benet discusses his path to becoming one of the most prominent founders in web3, and his vision for Protocol Labs.
-
In this talk, Hilmar Pétursson discusses why CCP Games is embracing crypto, shares his thoughts about different gaming economies and more.
-
a16z General Partner David George interviews Capital Group's Mark Casey on his investment philosophy and what sends him into what he calls "barnacle mode."
-
John Crowley, President and CEO of Biotechnology Innovation Organization (BIO), joins Jorge Conde, general partner at a16z Bio + Health.
-
We discuss our favorite books and reading recommendations from team a16z crypto for summer 2024 on the web3 with a16z podcast.
-
Anyscale's Robert Nishihara discusses the challenges of training and running AI models at scale, and how a focus on video data will change generative AI.
-
The Talent x Opportunity Fall 2024 cohort is a group of talented founders building companies that range from making it easy to find the style that best expresses who you are to providing real-world rewards through gaming.
-
Lawrence Ingrassia, author and journalist, joins Vineeta Agarwala, general partner, and Kris Tatiossian, editorial lead at a16z Bio + Health.
-
Tim Roughgarden, Scott Kominers, and Pranav Garimidi discuss incentives, market design and mechanism design within the infrastructure and application layers.
-
Jonathan Swerdlin, cofounder and CEO, and Mark Hyman, MD, cofounder and Chief Medical Officer of Function Health join Vijay Pande, general partner, and Daisy Wolf, investment partner of a16z Bio + Health.
-
a16z crypto research partners explore diverse aspects of cryptography, delving deeply into their respective research areas.
-
The Little Tech AgendaFeatured
The time has come to stand up for Little Tech. Bad government policies are now the #1 threat to Little Tech. We believe American technology supremacy, and the critical role that Little Tech startups play in ensuring that supremacy, is a first class political issue on par with any other.
-
Jiaming Song and Anjney Midha discuss Luma's Dream Machine 3D model that shows abilities to reason about the world across a variety of aspects.
-
Here's where AI agents and software can have the most immediate impact on your business, and make you more efficient and productive.
-
Pros and cons of existing NFT royalty designs, plus two new approaches to royalties that leverage incentive mechanisms.
-
Jonathan Bush, founder and CEO of Zus Health, and Chris Severn, cofounder and CEO of Turquoise Health, join Julie Yoo, general partner, and Colin Rom, head of public policy for a16z Bio + Health.
-
Generative AI is working its way into everything, and firms want to show they are implementing this new tech — especially those that serve the accounting market.
-
BNY's Akash Shah on the company's approach to adopting AI and what advice he would give to fintech startup founders.
-
Maggie Hsu and Pyrs Carvolth discuss the intricacies of GTM strategies, explore various models and motions, and walk through a comprehensive checklist.
-
Alasdair Monk discusses how generative AI is changing how developers — and the those building for developers — interact with the tools of their trade.
-
a16z General Partner Angela Strange, Plaid CEO Zach Perret, and Marqeta CEO Simon Khalaf discuss how AI and fintech will shape the future of banking.
-
Senate Bill 1047 is designed to apply to models trained above certain compute and cost thresholds. It also holds developers legally liable for the downstream use or modification of their models.
-
The most impactful way to fix healthcare is through improving the consumer experience, which has been largely ignored to date. In today’s modern world where you can order groceries, buy flight tickets, and wire money from your phone, taking care of yourself and navigating the healthcare system remains impossibly hard.
-
In this episode, originally recorded for the a16z Podcast, host Steph Smith interviews Pushmeet Kohli, DeepMind's VP of Research focused on AI for science. They are joined by a16z Bio + Health founding partner Vijay Pand...
-
A web3 with a16z podcast covering governance from the history of democracy to AI oversight boards at Meta, OpenAI, and Anthropic, and more.
-
The TxO grant program will facilitate entry and success in the technology industry and startup ecosystem by providing financial support for skill development, internship placement, and other networks designed for career advancement.
-
In this AI + a16z episode, Inngest CEO Tony Holdstock-Brown discusses the reality of running AI agents and multistep AI workflows in production.
-
In this latest episode on the State of AI, Ben and Marc discuss how small AI startups can compete with Big Tech’s massive compute and data scale advantages, reveal why data is overrated as a sellable asset, and unpack al...
-
Chronis Manolis, SVP and Chief Pharmacy Officer of UPMC Health Plan, joins Julie Yoo, general partner, Daisy Wolf, investment partner, and Will Shrank, venture partner, of a16z Bio + Health.
-
Finding predictable revenue in a flexible usage-based pricing model can be difficult. Frameworks for how to make it easier.
-
In this AI + a16z podcast episode, Mohammad Norouzi shares his story of building influential text-to-image models at Google and cofounding Ideogram.
-
In this episode, a16z General Partner Anjney Midha breaks down everything the tech community needs to know about SB-1047.
-
Understanding how pricing fundamentals shift when you’re launching additional products can help you capture the value those products create more quickly.
-
Brooke Boyarsky Pratt, founder and CEO of knownwell, joins Vineeta Agarwala, general partner at a16z Bio + Health.
-
We see three phases in the evolution of adopting GenAI in marketing: the development of marketing copilots, the introduction of marketing agents & the rise of an autonomous marketing team.
-
Addressing questions, clarifying misconceptions, and sharing his perspective, Justin Thaler discusses Jolt, our open source zkVM
-
Experts from a16z crypto discuss startup pricing strategy, consumer psychology, and business economics on web3 with a16z podcast.
-
5 strategies for finding product-market in web3, from new approaches to customer research to building incentive systems.
-
Matt Gleason discusses how to identify malicious actors on the internet, understand their targeting methods, and learn effective strategies to safeguard yourself and your assets.
-
Now is the time to reinvent the phone call. Thanks to gen AI, humans will spend time on the phone only when a call has value to them.
-
As Ozempic, Wegovy, Mounjaro, and Zepbound capture the healthcare spotlight, we’ve developed a series of episodes that go beyond the headlines and take you into conversations with the specialists. Our first guest is Carolyn Jasik, MD, Chief Medical Officer at Omada Health.
-
We stitched together two episodes from the a16z Podcast, featuring Anjney Midha interviewing Arthur Mensch (Mistral) and Stefano Ermon (Stanford).
-
The latest crypto regulation news, legislation, and frameworks released by regulatory agencies and bodies — curated by our policy team.
-
Michele Korver and Brian Quintenz discuss the nuances of policy and regulatory matters for web3 startups.
-
Optimism's Jing Wang discusses open source foundation stewardship, crypto superchain scaling, and more on web3 with a16z podcast.
-
AI can own B2B workflows by converting them into a feature or capability within the product. This is the potential that we believe SynthAI yields.
-
This is a 12-month program for early-career engineers and researchers with expertise at the intersection of hardware and software.
-
Vineeta Agarwala, MD, PhD, joins Luke Timmerman's The Long Run podcast on stage at the Life Science Innovation Northwest Conference.
-
In this episode of the AI + a16z podcast, a16z partners Guido Appenzeller and Matt Bornstein discuss the state of the generative AI market, about 18 months after it really kicked into high gear with the release of ChatGP...
-
a16z General Partner Alex Rampell recently spoke to CEO of Rocket Companies Varun Krishna about his newest role, AI, and the future of real estate.
-
May Fintech Newsletter: New a16z Fintech Podcast, Q&A With Rocket Companies’ Varun Krishna, and More
In May’s Fintech newsletter, we introduce our new podcast “In the Vault,” where we share exclusive conversations with financial industry leaders.
-
The stakes are high. The opportunities are profound. From the creation of new medicines to bolstering national defense, this is our vision for the AI-enabled future.
-
Regulators influenced by the big companies create barriers to entry for "little tech" and curtail innovation.
-
Security-startup founders Dean De Beer (Command Zero), Kevin Tian (Doppel), and Travis McPeak (Resourcely) share their thoughts on generative AI.
-
Mechanism design in web3 is both complex and fascinating because of the challenges and constraints of permissionless blockchain protocols
-
Mature code-generation technology, coupled with advanced generative AI image models, has shortened the journey from idea to fully operational application.
-
Kim Branson, PhD, SVP and Global Head of AI and Machine Learning for GSK, joins Vijay Pande, founding partner at a16z Bio + Health. Together, they talk about how AI has improved drug discovery and development, as Kim walks through all the ways AI can be deployed in the lab.
-
There’s likely a whole category of non-AI companies and products that can FINALLY exist *because of the productivity gains of AI.*
-
In 2009 Discord cofounder and CEO, Jason Citron, started building tools and infrastructure for games. Fast forward to today and the platform has over 200 million monthly active users. In this episode, Jason, alongside a1...
-
Jason Rosenthal discusses the best practices and ideas for finding product market fit
-
Ben Rubin discusses product market fit, and his journey of building Meerkat, Houseparty, and Here Not There Labs
-
In this AI + a16z episode, a16z's Zane Lackey and Joel de la Garza discuss how generative AI and LLMs could effect profound change in cybersecurity.
-
AI-native consumer products should consider user retention a core metric, and the following boosters can help founders build it.
-
Human nature fears the unknown, and with the rapid progress of AI, concerns naturally arise. Uncanny robocalls, data breaches, and misinformation floods are among the worries. But what about security in the era of large...
-
Dig into some of the most important must-knows and to-dos for founders and cultural leaders, including athletes, entertainers, and executives, when building a relationship.
-
The U.S. industrial base faces a series of risks that compromise our ability to remain globally competitive. AI is uniquely suited to tackle these complex challenges.
-
The latest crypto regulation news, legislation, and frameworks released by regulatory agencies and bodies — curated by our policy team.
-
In this episode of the AI + a16z podcast, Socket's Feross Aboukhadijeh and a16z's Joel de la Garza discuss the open-source software supply chain.
-
Behind Jolt — the most performant zkVM to date — with its a16z crypto research and engineering team makers on the web3 with a16z podcast.
Recent Investment News
-
Investing in Black Forest Labs
Anjney Midha -
Investing in Daylight
Guy Wuollet -
Investing in Saronic
Katherine Boyle -
Investing in Hebbia
Alex Immerman -
Investing in Formation Bio
Scott Kupor -
Investing in k-ID
Jonathan Lai -
Investing in Function Health
Vijay Pande -
Investing in knownwell
Vineeta Agarwala -
Investing in Decagon
Kimberly Tan -
Investing in Talkiatry
Scott Kupor -
Investing in Valar Labs
Vineeta Agarwala -
Investing in Yellow
Jonathan Lai -
Investing in Wiz
Sarah Wang -
Investing in Tennr
Kristina Shen -
Investing in Espresso
Ali Yahya -
Investing in Kaedim
Jonathan Lai -
Investing in Ideogram
Martin Casado -
Investing in EigenLayer
Ali Yahya -
Investing in Tigris
Martin Casado -
Investing in Upstash
Jennifer Li -
Investing in Crux
David Haber -
Investing in Doppel
Zane Lackey -
Investing in hyperexponential
Angela Strange -
Investing in Quora and Poe
David George -
Investing in Luma AI
Anjney Midha -
Investing in Distributional
Martin Casado -
Investing in Tome Biosciences
Jorge Conde -
Investing in Mistral
Anjney Midha -
Investing in Air Space Intelligence
David Ulevitch -
Investing in Pimlico
Sriram Krishnan -
Investing in Gate Bioscience
Vineeta Agarwala -
Investing in Prepared
David Ulevitch -
Investing in Blackbird
Arianna Simpson -
Investing in Proof of Play
Chris Dixon -
Investing in TipTop
Marc Andreessen -
Investing in Series AI
Joshua Lu -
Investing in Moment
David Haber -
Investing in Pahdo Labs
Jonathan Lai -
Investing in Socket
Zane Lackey -
Investing in Sound.xyz
Ali Yahya -
Investing in Apex
Katherine Boyle -
Investing in Captions
Bryan Kim -
Investing in ElevenLabs
Jennifer Li -
Investing in Gensyn
Ali Yahya -
Investing in Pomelo Care
Vineeta Agarwala -
Investing in Hippocratic AI
Julie Yoo -
Investing in Pinecone
Peter Levine -
Investing in Orbital Therapeutics
Vineeta Agarwala -
Investing in Radiant
David Ulevitch -
Investing in Function Oncology
Vineeta Agarwala -
Investing in Character.AI
Sarah Wang -
Investing in CCP Games
Jonathan Lai -
Investing in Coactive
Martin Casado -
Investing in Wingspan
David Ulevitch -
Investing in Believer
Andrew Chen -
Investing in Towns
Sriram Krishnan -
Investing in Svix
Matt Bornstein -
Investing in Replicate
Matt Bornstein -
Investing in Azra Games
Arianna Simpson -
Investing in Marker Learning
Annie Collins -
Investing in Snapser
Joshua Lu -
Investing in Macro
Kristina Shen -
Investing in Method
Anish Acharya -
Investing in Voldex
Andrew Chen -
Investing in Cygnvs
Angela Strange -
Investing in PLAI Labs
Arianna Simpson -
Investing in Seidr
Joshua Lu -
Investing in Aztec
Ali Yahya -
Investing in Setpoint
David Haber -
Investing in MotherDuck
Martin Casado -
Investing in Equals
Kristina Shen -
Investing in Rewind
David Ulevitch -
Investing in The Coterie
Anish Acharya -
Investing in MVMNT
Seema Amble -
Investing in Payall
Joe Schmidt -
Investing in Codi
Jeff Jordan -
Investing in PROOF
Sriram Krishnan -
Investing in Ready Player Me
Jonathan Lai -
Investing in Flow
Marc Andreessen -
Investing in IDRx
Jorge Conde -
Investing in VeeFriends
Chris Lyons -
Investing in Fly.io
Martin Casado -
Investing in Vicinitas Therapeutics
Jorge Conde -
Investing in Nash
Andrew Chen -
Investing in Cartography Biosciences
Jorge Conde -
Investing in Stoik
Seema Amble -
Investing in SCiFi Foods
Vijay Pande -
Investing in Omni Creator Products
Andrew Chen -
Investing in Flowcarbon
Arianna Simpson -
Investing in Metatheory
Andrew Chen -
Investing in Lightspark
Sriram Krishnan -
Investing in Turquoise Health
Julie Yoo -
Investing in Irreverent Labs
Arianna Simpson -
Investing in Lumos
Peter Levine -
Investing in Graphite
Peter Levine -
Investing in Convex
Martin Casado -
Investing in Bounce
Andrew Chen -
Investing in Spruce
Eddy Lazzarin